• Latest Posts

First patient dose completed for bladder cancer diagnostic drug 

Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation

Companies with exclusive rights to CRISPR diagnostic methods sign agreement

Report says 20% of global cancer deaths could be avoided

More News! 17 Oct 2022

Clinical trial of treatment for advanced solid tumors approved

Merck contributing to Jacobio Pharma colorectal cancer clinical trial


Agreement signed to advance therapy for autoimmune disease

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

Trial starts for treatment of warm autoimmune hemolytic anemia

CanSinoBIO to present latest data on inhaled COVID vaccine